Oregon Prescription Drug Affordability Board Meeting of Oct. 15, 2025
Oregon Prescription Drug Affordability Board · October 15, 2025
The Oregon Prescription Drug Affordability Board met Oct. 15, 2025, to hear public comment, continue drafting policy recommendations for its 2025 annual legislative report and to review methodology for drug affordability scoring. Board members debated PBM oversight, a possible 340B audit and how to use a new scoring rubric; insulin (glargine) data were discussed for upcoming reviews.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.